PatientProfiler: A network-based approach to personalized medicine
Veronica LombardiiD, Lorenzo Di RoccoiD, Eleonora MeoiD, Veronica VenafraiD, Elena Di NisioiD, Valerio Perticaroli, Mihail Lorentz Nicolaeasa, Chiara CencioniiD, Francesco SpallottaiD, Rodolfo NegriiD, Francesca SaccoiD, Livia PerfettoiD
Abstract
Deciphering the intricate mechanisms underlying reprogramming in cancer cells is a crucial challenge in oncology as it holds the key to advance our ability to diagnose and treat cancer patients. For this reason, comprehensive and patient-specific multi-omic characterization of tumor specimens has become increasingly common in clinical practice. While these efforts have advanced our understanding of the molecular mechanisms underlying breast cancer progression, the identification of personalized therapeutic approaches remains a distant goal. The main shortcoming is the absence of a robust computational framework to integrate and interpret the available multi-dimensional data and to drive translational solutions. To fill this gap, we developed PatientProfiler, a computational pipeline that leverages causal interaction data, annotated in our in-house manually-curated resource, SIGNOR, to address how the genetic and molecular background of single patients contributes to the establishment of a malignant phenotype. PatientProfiler is an open-source, R-based package composed of several functions that allows multi-omic data analysis and standardization, generation of patient-specific mechanistic models of signal transduction, and extraction of network-based prognostic biomarkers. To benchmark the tool, we retrieved genomic, transcriptomic, (phospho)proteomic, and clinical data derived from 122 treatment-naive breast cancer biopsies, available at the CPTAC portal. Thanks to this approach, we identified patient-specific mechanistic models (one patient, one network) that recapitulate dysregulated signaling pathways in breast cancer. This collection of models provides valuable insights into the underlying mechanisms of tumorigenesis and disease progression. Moreover, in-depth topological exploration of these networks has allowed us to define seven communities (subnetworks), each associated with a unique transcriptomic signature and a distinct prognostic value. In summary, our work demonstrates that PatientProfiler is a tool for patient-specific network analysis, advancing personalized medicine towards the identification of actionable biomarkers and tailored therapeutic strategies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SignalingProfiler 2.0: a network-based approach to bridge multi-omics data to phenotypic hallmarks
Veronica Venafra, Francesca Sacco, Livia Perfetto·bioRxiv·Jan 25, 2024
- OncoProExp: An Interactive Shiny Web Application for Comprehensive Cancer Proteomics and Phosphoproteomics Analysis
Edris Sharif Rahmani, Prakash Lingasamy, … Vijayachitra Modhukur·Computational and Structural Biotechnology JournalPeer-reviewed·Jan 1, 2025
- CGPA: multi-context insights from the cancer gene prognosis atlas
Biwei Cao, Xiaoqing Yu, … Xuefeng Wang·bioRxiv·Jul 19, 2024
- PROMO: An interactive tool for analyzing clinically-labeled multi-omic cancer datasets
Dvir Netanely, Neta Stern, … Ron Shamir A·BMC BioinformaticsPeer-reviewed·Dec 1, 2019
- A network model for patient-derived drug response in breast cancer integrating multi-omics datasets.
Banabithi Bose, Barbara E. Stranger, Serdar Bozdag·bioRxiv·Jun 9, 2025
- Integrated Multi-Omics Analysis for the Identification of Disease-Associated Variations and Prognostic Biomarkers in Triple-Negative Breast Cancer (TNBC)
NAGENDRA MANNEKUNTA, Elamathi Natarajan·bioRxiv·May 29, 2026